Get the Stockscreener App
1.04
1.89%
-0.02
After Hours:
1.04
Hoth Therapeutics Inc stock is traded at $1.04, with a volume of 91,775.
It is down -1.89% in the last 24 hours and down -13.33% over the past month.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
See More
Previous Close:
$1.06
Open:
$1.05
24h Volume:
91,775
Relative Volume:
0.21
Market Cap:
$16.13M
Revenue:
-
Net Income/Loss:
$-7.51M
P/E Ratio:
-0.7879
EPS:
-1.32
Net Cash Flow:
$-8.02M
1W Performance:
+4.00%
1M Performance:
-13.33%
6M Performance:
-14.05%
1Y Performance:
+26.89%
1-Day Range:
$1.025
$1.07
1-Week Range:
$0.9702
$1.0779
52-Week Range:
$0.6554
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
Name
Hoth Therapeutics Inc
Sector
Industry
Phone
(646)756-2997
Address
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Compare HOTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.04 | 16.45M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-19 | Initiated | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc Stock (HOTH) Latest News
Hoth Therapeutics Files Dual U.S. Provisional Patents to Expand Oncology Dermatology IP - Digital Health News
Hoth Therapeutics Files Two Provisional Patents To Build Oncology Dermatology Platform - Nasdaq
Hoth Therapeutics Files Two US Provisional Patents for Oncology-Focused Dermatology Platform; Shares Rise - marketscreener.com
Hoth Therapeutics Files New Patents to Expand Oncology Dermatology Platform - Contract Pharma
Hoth therapeutics files patents for oncology skin toxicity treatments By Investing.com - Investing.com Canada
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments By Investing.com - Investing.com South Africa
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments - Investing.com
Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform - PR Newswire
Hoth Therapeutics’ Stock Triples On Promising Cancer Trial Data for Skin Toxicity Therapy: Retail’s Excited - MSN
Hoth Therapeutics (NASDAQ:HOTH) Stock Price Down 2.9% – Here’s What Happened - Defense World
Why Hoth Therapeutics Inc. stock could outperform in 2025Trade Entry Report & Free Technical Pattern Based Buy Signals - Bölüm Sonu Canavarı
Why Hoth Therapeutics Inc. stock remains undervaluedTrade Signal Summary & Precise Buy Zone Identification - DonanımHaber
Is Hoth Therapeutics Inc. stock trading near support levelsJuly 2025 Retail & Weekly Return Optimization Alerts - Улправда
Wave Life Sciences (WVE) Stock News Today: Oppenheimer Lifts Target to $32 as WVE-007 Obesity Data Fuels Volatility - ts2.tech
Aug Highlights: Is Hoth Therapeutics Inc stock gaining market shareWeekly Profit Report & Long-Term Capital Growth Strategies - moha.gov.vn
Sentiment Review: Why Hoth Therapeutics Inc stock remains undervaluedJuly 2025 EndofMonth & Safe Entry Zone Tips - moha.gov.vn
Published on: 2025-12-10 00:57:10 - moha.gov.vn
Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal - ts2.tech
Hoth Therapeutics (HOTH) Price Target Increased by 12.50% to 4.59 - Nasdaq
D. Boral Capital Maintains Hoth Therapeutics (HOTH) Buy Recommendation - Nasdaq
Hoth Therapeutics stock rises after pipeline update By Investing.com - Investing.com India
Hoth Therapeutics stock rises after pipeline update - Investing.com
Hoth Therapeutics, Inc. Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated Ht-Kit, Advancing Ht-001 Phase 2, and New Gdnf Metabolic Program - MarketScreener
Hoth Therapeutics advances pipeline with four clinical programs By Investing.com - Investing.com India
Hoth Therapeutics advances pipeline with four clinical programs - Investing.com
Hoth Therapeutics Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated HT-KIT, Advancing HT-001 Phase 2, and New GDNF Metabolic Program - PR Newswire
Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025 - Eastern Progress
Bearish Setup: Is Hoth Therapeutics Inc. stock trading near support levelsQuarterly Risk Review & Real-Time Volume Analysis Alerts - moha.gov.vn
Wall Street analysts’ outlook for Hoth Therapeutics Inc (HOTH) - Setenews
What technical signals suggest for Hoth Therapeutics Inc. stockWeekly Trade Report & Fast Entry Momentum Trade Alerts - newser.com
Will Hoth Therapeutics Inc. stock maintain growth storyJuly 2025 Reactions & Consistent Profit Trade Alerts - newser.com
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research By Investing.com - Investing.com Nigeria
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research - Investing.com
Hoth Therapeutics accepted into Nvidia Connect Program, expanding its AI and accelerated computing capabilities - MarketScreener
Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and Accelerated Computing Capabilities - PR Newswire
Can Hoth Therapeutics Inc. stock deliver surprise earnings beat2025 Bull vs Bear & Daily Market Momentum Tracking - newser.com
Can Hoth Therapeutics Inc. stock maintain growth trajectoryQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Is Hoth Therapeutics Inc a good long term investmentVolume Weighted Average Price & Free Superior Profit Margins - earlytimes.in
Can Hoth Therapeutics Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
What moving averages say about Hoth Therapeutics Inc.Earnings Beat & Target Return Focused Picks - newser.com
Published on: 2025-11-19 05:13:43 - newser.com
Hoth Therapeutics Inc Stock (HOTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):